FDA authorised first next-generation sequencer

The USA Food and Drug Administration (FDA) has granted marketing authorisation for the first high-throughput (next-generation) genomic sequencer. Sequencing technologies have advanced dramatically, and today a human genome can be sequenced in about 24 hours for less than 5,000 USD. This is a rare example of technology development in which faster, cheaper, and better have coincided. With a platform that took nearly a decade to develop, clinicians can selectively look for an almost unlimited number of genetic changes. Read more here.